Can a simple blood test predict ovarian cancer relapse?
NCT ID NCT05027828
First seen Apr 25, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study is for women newly diagnosed with a common type of ovarian cancer. Researchers will collect blood samples before surgery, after chemotherapy, and during follow-up treatment to look for tumor DNA. The goal is to see if this DNA test can predict how well the maintenance drug works and catch a return of the cancer early. About 100 participants will be followed over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE SEROUS OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.